Full Description
This issue is a dedicated supplement published in addition to the regular issues of 'Digestive Diseases' focussing on one specific topic. 'Digestive Diseases' is a well-respected, international peer-reviewed journal in Gastroenterology. Supplement issues are included in the subscription.
Contents
Introduction; Dealing with Our 'In-Vironment': New Apects of Inflammatory Bowel Disease Pathogenesis and Therapy: Rogler, G.; Genetic Risk Factors in IBD: Impaired Control of the 'In-Vironment'?; Genes and 'In-Vironment': How Will Our Concepts on the Pathophysiology of Inflammatory Bowel Disease Develop in the Future? Fiocchi, C.; IBD: The 'In-Vironment' out of Control?; Inflammatory Bowel Disease: Dysfunction of Autophagy? Scharl, M.; Rogler, G.; Environmental Factors and Their Impact on the Intestinal Microbiota: A Role for Human Disease? Biedermann, L.; Rogler, G.; Environment and 'In-Vironment'; Why and Where to Look in the Environment with Regard to the Etiology of Inflammatory Bowel Disease: Bernstein, C.N.; Does Our Food (Environment) Change Our Gut Microbiome ('In-Vironment'): A Potential Role for Inflammatory Bowel Disease? de Wouters, T.; Dore, J.; Lepage, P.; Danger-Associated Molecular Patterns and Inflammatory Bowel Disease: Is There a Connection? Mueller, C.; Microparticles and Their Impact on Intestinal Immunity: Becker, H.M.; Bertschinger, M.M.; Rogler, G.; Treatment Decisions Made Easy: Do We Have the Disease Markers We Need?; Circulating Antibodies against Bacterial Wall Products: Are There Arguments for Early Immunosuppression? Rieder, F.; Kugathasan, S.; Clinical Risk Factors for Complicated Disease: How Reliable Are They? Zallot, C.; Peyrin-Biroulet, L.; Intestinal Absorption and Vitamin Levels: Is a New Focus Needed? Vavricka, S.R.; Rogler, G.; Changing the 'In-Vironment' for Therapy; Specific Probiotics or 'Fecal Transplantation': Kruis, W.; Mucosal Protection by Phosphatidylcholine: Stremmel, W.; Ehehalt, R.; Staffer, S.; Stoffels, S.; Mohr, A.; Karner, M.; Braun, A.; Topical Therapy: Gross, V.; The Risks and Benefits of Early Immunosuppression and Biological Therapy: Sands, B.E.; The Classical Immunosuppression: Overrated or Underused?; Deep Remission: A New Concept? Colombel, J.-F.; Louis, E.; Peyrin-Biroulet, L.; Sandborn, W.J.; Panaccione, R.; Methotrexate: Underused and Ignored? Herfarth, H.H.; Long, M.D.; Isaacs, K.L.; Extended Abstract: Tacrolimus and Cyclosporine in Inflammatory Bowel Disease: Stange, E.F.; Biologicals and Beyond; Biological Treatment of Crohn's Disease: Nielsen, O.H.; Bjerrum, J.T.; Seidelin, J.B.; Nyberg, C.; Ainsworth, M.; Stem Cells as Treatment in Inflammatory Bowel Disease: Hawkey, C.J.; The Future of Inflammatory Bowel Disease Therapy: Where Do We Go from Here? Sandborn, W.J.
